Clinical trial
Blood Donation Screening for Babesia Microti by Real-time Polymerase Chain Reaction (PCR) and by Indirect Flourescent Antibody (IFA) Assays
NCT01528449 is registered in ClinicalTrials.gov with Imugen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Donation Screening for Babesia Microti by Real-time Polymerase Chain Reaction (PCR) and by Indirect Flourescent Antibody (IFA) Assays
- Lead sponsor
- Imugen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- September 30, 2014
- Enrollment
- 90,116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
transfusion transmitted babesiosis